Now live at #AACR26 — join Sam Lawn for “ZW191 – a differentiated FRα-targeted topoisomerase I antibody-drug conjugate active in combinat...

Zymeworks Inc.· @ZymeworksInc · X·2026-04-21 00:00· 2026-04-21评分60

正文 · 原文

Now live at #AACR26 — join Sam Lawn for “ZW191 – a differentiated FRα-targeted topoisomerase I antibody-drug conjugate active in combination with standard-of-care therapies.”

If you’re onsite, stop by Poster Board 4 in Poster Section 13 between 9:00 am - 12:00 pm PT to connect

热度 1 · 1 赞 · 0 回复 · 0 转发

会议摘要

CT306NCT06555744按代号 ZW191 对上

Phase 1 first-in-human multicenter open-label study of ZW191, a folate receptor α (FRα)-targeting antibody-drug conjugate (ADC), in patients with advanced solid tumors: Part 1 dose-escalation results

Patricia LoRusso, David Sommerhalder, Kosei Hasegawa, Kenichi Harano, David S. Tan, Noboru Yamamoto, David M. O’Malley, Kathleen N. Moore, Sarah E. Church, Lin Lu, Sabeen Mekan, Pranshul Chauha, Jung-Yun Lee

读摘要原文 →

来源：Zymeworks Inc. · x.com